EA200200311A1
(en)
|
1999-08-31 |
2002-08-29 |
Максиа Фармасьютикалз, Инк. |
BENZYLIDENE-TIAZOLIDINDIONES AND ANALOGUES AND THEIR APPLICATION FOR THE TREATMENT OF DIABETES
|
MXPA03008117A
(en)
*
|
2001-03-07 |
2004-11-12 |
Incyte San Diego Inc |
Heterocyclic derivatives for the treatment of cancer and other proliferative diseases.
|
CA2473156A1
(en)
|
2001-03-08 |
2002-09-19 |
Incyte San Diego, Inc. |
Rxr activating molecules
|
TWI311133B
(en)
|
2001-04-20 |
2009-06-21 |
Eisai R&D Man Co Ltd |
Carboxylic acid derivativeand the salt thereof
|
JP2004532230A
(en)
*
|
2001-04-30 |
2004-10-21 |
アラクノーバ・セラピューティックス・リミテッド |
Treatment of scarring and related conditions using PPAR-gamma activator
|
EP1394147A4
(en)
*
|
2001-06-04 |
2007-10-24 |
Eisai R&D Man Co Ltd |
Carboxylic acid derivative and medicine comprising salt or ester of the same
|
WO2003016267A1
(en)
*
|
2001-08-17 |
2003-02-27 |
Incyte San Diego Incorporated |
Oxime derivatives for the treatment of dyslipidemia and hypercholesteremia
|
EP1456187A4
(en)
|
2001-11-15 |
2005-02-09 |
Incyte San Diego Inc |
N-substituted heterocycles for the treatment of hypercholesteremia, dyslipidemia and other metabolic disorders, cancer, and other diseases
|
AU2002351731A1
(en)
|
2001-12-14 |
2003-06-30 |
Novo Nordisk A/S |
Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
|
FR2833949B1
(en)
*
|
2001-12-21 |
2005-08-05 |
Galderma Res & Dev |
NOVEL PPARy RECEPTOR ACTIVATION LIGANDS, PROCESS FOR THEIR PREPARATION AND THEIR USE IN HUMAN MEDICINE AND COSMETICS
|
US6908939B2
(en)
|
2001-12-21 |
2005-06-21 |
Galderma Research & Development S.N.C. |
Biaromatic ligand activators of PPARγ receptors
|
FR2836683B1
(en)
*
|
2002-03-01 |
2006-06-23 |
Galderma Res & Dev |
NOVEL PPARy RECEPTOR ACTIVATION LIGANDS, PROCESS FOR THEIR PREPARATION AND THEIR USE IN HUMAN MEDICINE AND COSMETICS
|
US7196108B2
(en)
|
2002-03-08 |
2007-03-27 |
Incyte San Diego Inc. |
Bicyclic heterocycles for the treatment of diabetes and other diseases
|
US7102000B2
(en)
|
2002-03-08 |
2006-09-05 |
Incyte San Diego Inc. |
Heterocyclic amide derivatives for the treatment of diabetes and other diseases
|
EP1558591B1
(en)
|
2002-10-07 |
2014-05-07 |
The Regents of The University of California |
Modulation of anxiety through blockade of anandamide hydrolysis
|
RU2005115842A
(en)
*
|
2002-10-24 |
2006-03-10 |
Мерк Патент ГмбХ (DE) |
METHYLENE DERIVATIVES
|
PL378238A1
(en)
|
2002-11-19 |
2006-03-20 |
Galderma Research & Development, S.N.C. |
Biaromatic compounds which activate ppar-gama type receptors, and use thereof in cosmetic or pharmaceutical compositions
|
FR2847251B1
(en)
*
|
2002-11-19 |
2006-11-17 |
|
NOVEL BI-AROMATIC ACTIVATED PPARy RECEPTOR-ACTIVE COMPOUNDS AND THEIR USE IN COSMETIC OR PHARMACEUTICAL COMPOSITIONS
|
FR2847580B1
(en)
*
|
2002-11-25 |
2006-03-03 |
Galderma Res & Dev |
NOVEL BI-AROMATIC RECEPTOR-ACTIVATING COMPOUNDS OF PPARy TYPE AND THEIR USE IN COSMETIC OR PHARMACEUTICAL COMPOSITIONS
|
PL376736A1
(en)
*
|
2002-11-25 |
2006-01-09 |
Galderma Research & Development, S.N.C. |
Biphenyl compounds which activate ppar-gamma type receptors and use thereof in cosmetic or pharmaceutical compositions
|
FR2848553B1
(en)
*
|
2002-12-12 |
2007-03-30 |
Galderma Res & Dev |
NOVEL MODULATING COMPOUNDS OF PPARY RECEPTORS AND THEIR USE IN COSMETIC OR PHARMACEUTICAL COMPOSITIONS
|
CA2506732A1
(en)
|
2002-12-12 |
2004-06-24 |
Galderma Research & Development, S.N.C. |
Compounds which modulate ppar.gamma. type receptors, and use thereof in cosmetic or pharmaceutical compositions
|
US20050014767A1
(en)
*
|
2003-01-29 |
2005-01-20 |
Magnus Pfahl |
Benzoxazole, benzothiazole, and benzimidazole derivatives for the treatment of cancer and other diseases
|
US20050038098A1
(en)
*
|
2003-04-18 |
2005-02-17 |
Catherine Tachdjian |
Substituted dihydronaphthalene and isochroman compounds for the treatment of metabolic disorders, cancer and other diseases
|
FR2856401B1
(en)
*
|
2003-06-20 |
2010-02-12 |
Galderma Res & Dev |
NOVEL MODULATING COMPOUNDS OF PPARGAMMA RECEPTORS AND THEIR USE IN COSMETIC OR PHARMACEUTICAL COMPOSITIONS
|
EP1638964B1
(en)
*
|
2003-06-20 |
2011-07-27 |
Galderma Research & Development |
Novel compounds that modulate ppar-gamma type receptors, and use thereof in cosmetic or pharmaceutical compositions
|
FR2869903B1
(en)
*
|
2004-05-06 |
2006-06-23 |
Galderma Res & Dev |
NOVEL BI-AROMATIC RECEPTOR ACTIVATOR COMPOUNDS OF THE PPARY TYPE, PROCESS FOR THEIR PREPARATION AND THEIR USE IN COSMETIC OR PHARMACEUTICAL COMPOSITIONS
|
DE602005019555D1
(en)
*
|
2004-05-06 |
2010-04-08 |
Galderma Res & Dev |
BIAROMATIC COMPOUNDS ACTIVATING PPAR (GAMMA) TYPE RECEPTORS, PROCESS FOR THEIR PREPARATION AND THEIR USE IN COSMETIC OR PHARMACEUTICAL COMPOSITIONS
|
KR100619441B1
(en)
*
|
2004-06-30 |
2006-09-08 |
서울옵토디바이스주식회사 |
Growth method of easy remove Sudstate
|
FR2874379B1
(en)
*
|
2004-08-17 |
2006-10-27 |
Galderma Res & Dev |
NOVEL BI-AROMATIC RECEPTOR ACTIVATOR COMPOUNDS OF THE PPAR TYPE AND THEIR USE IN COSMETIC OR PHARMACEUTICAL COMPOSITIONS
|
FR2874378B1
(en)
*
|
2004-08-17 |
2006-10-27 |
Galderma Res & Dev |
NOVEL BI-AROMATIC RECEPTOR ACTIVATOR COMPOUNDS OF THE PPAR TYPE AND THEIR USE IN COSMETIC OR PHARMACEUTICAL COMPOSITIONS
|
ES2315909T3
(en)
*
|
2004-08-17 |
2009-04-01 |
GALDERMA RESEARCH & DEVELOPMENT |
NEW BIOAROMATIC COMPOUNDS THAT ARE ACTIVATORS OF THE RECEPTORS OF THE PPAR TYPE AND THEIR USE IN COSMETIC AND PHARMACEUTICAL COMPOSITIONS.
|
DE602005010444D1
(en)
|
2004-08-17 |
2008-11-27 |
Galderma Res & Dev |
Novel Bioaromatic PPAR-RECEPTORS ACTIVE COMPOSITIONS AND THEIR USE IN COSMETIC OR PHARMACEUTICAL COMPOSITIONS
|
EP1814871B1
(en)
*
|
2004-11-19 |
2011-03-02 |
Galderma Research & Development |
Compounds that modulate ppary type receptors, and use thereof in cosmetic or pharmaceutical compositions
|
FR2878247B1
(en)
|
2004-11-19 |
2008-10-03 |
Galderma Res & Dev |
NOVEL MODULATING COMPOUNDS OF PPARY RECEPTORS AND THEIR USE IN COSMETIC OR PHARMACEUTICAL COMPOSITIONS
|
JP5154406B2
(en)
|
2005-04-13 |
2013-02-27 |
アステックス、セラピューティックス、リミテッド |
Pharmaceutical compounds
|
FR2887444A1
(en)
*
|
2005-06-28 |
2006-12-29 |
Oreal |
BENZYLIDENE-1,3-THIAZOLIDINE-2,4-DIONES COMPOUNDS, THEIR USES AND COMPOSITIONS FOR STIMULATING OR INDUCING THE PUSH OF KERATIN FIBERS AND / OR BRAKING THEIR FALL AND / OR INCREASING THEIR DENSITY
|
US20070059265A1
(en)
*
|
2005-06-28 |
2007-03-15 |
L'oreal |
Benzylidene-1,3-thiazolidine-2,4-dione compounds for stimulating or inducing the growth and/or for reducing the loss and/or for increasing the density of keratin fibers
|
FR2892412B1
(en)
*
|
2005-10-26 |
2008-05-16 |
Galderma Res & Dev |
BIAROMATIC COMPOUNDS MODULATORS OF PPARS
|
FR2897536A1
(en)
*
|
2006-02-17 |
2007-08-24 |
Galderma Res & Dev |
USE OF MURAGLITAZAR FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF DERMATOLOGICAL DISEASES
|
US7754725B2
(en)
|
2006-03-01 |
2010-07-13 |
Astex Therapeutics Ltd. |
Dihydroxyphenyl isoindolymethanones
|
US20090099240A1
(en)
*
|
2006-10-02 |
2009-04-16 |
N.V. Organon |
Methods for treating energy metabolism disorders by inhibiting fatty acid amide hydrolase activity
|
EP2081891A2
(en)
|
2006-10-12 |
2009-07-29 |
Astex Therapeutics Limited |
Pharmaceutical compounds having hsp90 inhibitory or modulating activity
|
GB0620259D0
(en)
|
2006-10-12 |
2006-11-22 |
Astex Therapeutics Ltd |
Pharmaceutical compounds
|
JP5721949B2
(en)
|
2006-10-12 |
2015-05-20 |
アステックス、セラピューティックス、リミテッドAstex Therapeutics Limited |
Compound drug
|
WO2008044045A1
(en)
|
2006-10-12 |
2008-04-17 |
Astex Therapeutics Limited |
Pharmaceutical combinations
|
US8916552B2
(en)
|
2006-10-12 |
2014-12-23 |
Astex Therapeutics Limited |
Pharmaceutical combinations
|
EP2073804B1
(en)
|
2006-10-12 |
2017-09-13 |
Astex Therapeutics Limited |
Hydroxy-substituted benzoic acid amide compounds for use in the treatment of pain
|
US7803940B2
(en)
|
2006-11-24 |
2010-09-28 |
Takeda Pharmaceutical Company Limited |
Heteromonocyclic compound or a salt thereof having strong antihypertensive action, insulin sensitizing activity and the like production thereof and use thereof for prophylaxis or treatment of cardiovascular diseases, metabolic diseases and/or central nervous system diseases
|
FR2917084B1
(en)
*
|
2007-06-05 |
2009-07-17 |
Galderma Res & Dev |
NOVEL 3-PHENYL PROPANOIC ACID DERIVATIVES OF PPAR-TYPE RECEPTORS, THEIR METHOD OF PREPARATION AND THEIR USE IN COSMETIC OR PHARMACEUTICAL COMPOSITIONS
|
FR2917086B1
(en)
*
|
2007-06-05 |
2009-07-17 |
Galderma Res & Dev |
NOVEL 3-PHENYL ACRYLIC ACIDIC ACID DERIVATIVES OF PPAR TYPE RECEPTORS, THEIR METHOD OF PREPARATION AND THEIR USE IN COSMETIC OR PHARMACEUTICAL COMPOSITIONS.
|
JP2011502148A
(en)
*
|
2007-10-31 |
2011-01-20 |
メルク・シャープ・エンド・ドーム・コーポレイション |
P2X3 receptor antagonist for the treatment of pain
|
GB0806527D0
(en)
|
2008-04-11 |
2008-05-14 |
Astex Therapeutics Ltd |
Pharmaceutical compounds
|
US20090258914A1
(en)
*
|
2008-04-15 |
2009-10-15 |
Burnham Institute For Medical Research |
Inhibitor of Anti-Apoptotic Proteins
|
MX2011001150A
(en)
|
2008-07-31 |
2011-03-29 |
Takeda Pharmaceutical |
Solid pharmaceutical composition.
|
US20100158829A1
(en)
*
|
2008-12-24 |
2010-06-24 |
Conopco, Inc., D/B/A Unilever |
Method and Composition for Color Modulation
|
MA33071B1
(en)
|
2009-01-30 |
2012-02-01 |
Takeda Pharmaceutical |
Composite of intensive nucleus and its use
|
FR2969149B1
(en)
*
|
2010-12-16 |
2012-12-28 |
Oreal |
PROCESS FOR DEPIGMENTING KERATINIC MATERIALS USING RESORCINOL DERIVATIVE COMPOUNDS
|
WO2013024898A1
(en)
|
2011-08-18 |
2013-02-21 |
日本新薬株式会社 |
Heterocyclic derivative and pharmaceutical drug
|
KR101485247B1
(en)
*
|
2012-06-26 |
2015-01-22 |
중앙대학교 산학협력단 |
Novel biphenyl-3-carboxamide derivatives or salt thereof and pharmaceutical composition for treating or preventing autoimmune diseases comprising the same
|
KR101829290B1
(en)
*
|
2014-12-24 |
2018-02-19 |
주식회사 엘지화학 |
Biaryl derivatives as gpr120 agonists
|
CN118184545A
(en)
*
|
2023-03-22 |
2024-06-14 |
沈阳药科大学 |
Compound, preparation method thereof and application of compound in preparation of sEH inhibitor and PPARs agonist
|